Gland Pharma shares made a strong debut on BSE and NSE today. Its shares rose to as much as ₹1,850 on BSE, up 23% compared to issue price of ₹1,500. The pharma company’s initial public offer (IPO), which closed on November 11, was subscribed two times.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
